Literature DB >> 12768916

Vascular MRI in the diagnosis and therapy of the high risk atherosclerotic plaque.

Jolanda J Wentzel1, Silvia H Aguiar, Zahi A Fayad.   

Abstract

Disruption of a high risk plaque is known as the primary cause of cardiovascular events. Characterization of arterial wall components has become an essential adjunct in the identification of patients with plaques prone to rupture. Magnetic Resonance Imaging (MRI) has been revealed as one of the noninvasive tools possibly capable of identifying and characterizing high risk atherosclerotic plaque. MRI may facilitate diagnosis, and guide and serially monitor interventional and pharmacological treatment of atherosclerotic disease. In addition, it permits the simultaneous assessment of the anatomy, morphology, and hemodynamics for the study of flow-induced atherogenesis. It possibly will identify asymptomatic patients with subclinical atherosclerosis. This has potential significance for the improvement of strategies in primary and secondary prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768916     DOI: 10.1046/j.1540-8183.2003.08024.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  5 in total

Review 1.  Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventions.

Authors:  Douglas S Jacoby; Emile R Mohler III; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

2.  Imaging of unstable atherosclerotic lesions.

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

Review 3.  Imaging of atherosclerotic plaque.

Authors:  Mario A Pulido; Dominick J Angiolillo; Marco A Costa
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

4.  Three-dimensional T2-weighted MRI of the human femoral arterial vessel wall at 3.0 Tesla.

Authors:  Zhuoli Zhang; Zhaoyang Fan; Timothy J Carroll; YiuCho Chung; Peter Weale; Renate Jerecic; Debiao Li
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

Review 5.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.